| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
CL264 manufacturers
- CL264
-
- $47.00
-
2026-07-27
- CAS:1510712-69-2
- Purity: 99.87%
- Supply Ability: 10g
- CL264
-
- $47.00
-
2026-07-27
- CAS:1510712-69-2
- Purity: 99.87%
- Supply Ability: 10g
|
| Product Name: | CL264 | | Synonyms: | CL264;Glycine, N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl]-;CL264,CL-264;(4-((6-amino-2-(butylamino)-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl)benzoyl)glycine;CL264, 10 mM in DMSO | | CAS: | 1510712-69-2 | | MF: | C19H23N7O4 | | MW: | 413.43 | | EINECS: | | | Product Categories: | | | Mol File: | 1510712-69-2.mol |  |
| | CL264 Chemical Properties |
| density | 1.427±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: 2mg/mL, clear | | pka | 3.65±0.10(Predicted) | | form | Solid | | color | Brown to gray |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | CL264 Usage And Synthesis |
| Uses | CL264 is a TLR7-specific agonist for innate immune signals research[1]. | | IC 50 | TLR7 | | References | [1] Butterfield JSS, et al. TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer. Hum Gene Ther Methods. 2019 Jun;30(3):81-92. DOI:10.1089/hgtb.2019.013 |
| | CL264 Preparation Products And Raw materials |
|